SciELO - Scientific Electronic Library Online

 
vol.80 número4Estudio de parámetros de normalidad en relación a la edad con el Tomógrafo Óptico de CoherenciaImplante de válvula de Ahmed. Nuestra experiencia 1995-2003 índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

Compartir


Archivos de la Sociedad Española de Oftalmología

versión impresa ISSN 0365-6691

Resumen

VILLEGAS BECERRIL, E; FERNANDEZ MOLINA, F; GONZALEZ, R  y  GALLARDO GALERA, JM. Serum IGF-I levels in retinopathy of prematurity. New indications for ROP screening. Arch Soc Esp Oftalmol [online]. 2005, vol.80, n.4, pp.233-238. ISSN 0365-6691.

Objective: To determine the IGF-I serum levels in premature infants with the objective of being able to use these levels as an indicator of the need for exploration in a screening program for retinopathy of prematurity (ROP). Methods: This was a comparative study in which IGF-I levels were measured in every infants’ serum during the first exploration in the 4 to 6 postnatal weeks. The degree of ROP and a variety of morbidity factors were evaluated, including the presence of intraventricular haemorrhage, sepsis, need for blood transfusion and the number of days of mechanical ventilation. Results: The average IGF-I values during the first 4 to 6 postnatal weeks were lowest in the ROP cases (10.75 µg/L SD 16.053) while the NO-ROP cases yielded higher values (29.75 µg/L, SD 13.022). The Mann-Whitney U test showed a value of P for the IGF-I values of 0.004, indicating significant differences between the groups with or without ROP. Conclusions: The low IGF-I serum levels in ROP infants in comparison with the NO-ROP cases, suggest that this marker could be used as an indicator in the screening for ROP.

Palabras clave : Retinopathy; prematurity; insulin-like growth factor; ROP.

        · resumen en Español     · texto en Español

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons